Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Change in Cash (2016 - 2025)

Orthofix Medical's Change in Cash history spans 16 years, with the latest figure at $19.2 million for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash fell 63.96% year-over-year to $19.2 million, compared with a TTM value of -$623000.0 through Dec 2025, down 101.3%, and an annual FY2025 reading of -$623000.0, down 101.3% over the prior year.
  • Change in Cash for Q4 2025 was $19.2 million at Orthofix Medical, up from -$2.7 million in the prior quarter.
  • The five-year high for Change in Cash was $53.2 million in Q4 2024, with the low at -$25.3 million in Q1 2025.
  • Average Change in Cash over 5 years is -$585300.0, with a median of -$1.4 million recorded in 2021.
  • Year-over-year, Change in Cash crashed 1032.92% in 2024 and then skyrocketed 1477.26% in 2025.
  • Tracing OFIX's Change in Cash over 5 years: stood at $4.6 million in 2021, then plummeted by 120.73% to -$960000.0 in 2022, then skyrocketed by 526.46% to $4.1 million in 2023, then surged by 1199.07% to $53.2 million in 2024, then plummeted by 63.96% to $19.2 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Change in Cash are $19.2 million (Q4 2025), -$2.7 million (Q3 2025), and $8.2 million (Q2 2025).